DEFA14A: Identiv Announces Strategic Shift, Divests Security Business to Focus on IoT Growth

Identiv is selling its security and logical reader assets for $145 million to concentrate on its IoT business, appointing Kirsten Newquist as the future CEO of the remaining entity.

Summary

• Identiv completed a strategic review, deciding to divest its security and logical reader assets for $145 million in cash to focus on its IoT business.
• Kirsten Newquist has been appointed as the future CEO of the IoT business upon the transaction's closure.
• Q1 2024 revenue was $22.5 million, within the guidance range, with GAAP gross margin at 37% and non-GAAP gross margin at 40%.
• The company expects the asset sale to close in Q3 2024.
• Identiv anticipates Q2 2024 revenue to be in the range of $23 to $25 million.
• The company is transitioning the majority of its RFID production to its Thailand facility by the end of Q1 2025 to capitalize on lower costs.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the company reported a decrease in revenue and a net loss, the strategic decision to focus on the IoT business and the appointment of a new CEO are viewed favorably. The expected closing of the asset sale and the transition to the Thailand facility are also positive developments.

Positives

• The divestiture of the security business will provide $145 million in capital to invest in the IoT business.
• Appointment of Kirsten Newquist as CEO of the IoT business is expected to bring strong leadership and industry expertise.
• Q1 2024 gross margins showed improvement, with non-GAAP gross margin reaching 40%.
• Premises business showed strength, with software, services, and recurring revenues growing to 27% of Q1 revenues.
• The transition of production to the Thailand facility is expected to lower costs and improve margins.
• The company secured a new 2-year customer contract for a smart home application.

Negatives

• Q1 2024 revenue decreased by $3.5 million compared to Q1 2023.
• The decrease in Identity segment revenue was related to RFID-enabled IoT products, primarily from Wiliot.
• GAAP net loss attributable to common shareholders was $4.8 million in Q1 2024, compared to a net loss of $3.0 million in Q1 2023.
• Non-GAAP adjusted EBITDA for Q1 2024 was negative $1.4 million, compared to negative $0.9 million in the prior year period.
• The company is exiting some very low margin business that doesn't justify the expense of relocating to Thailand, nor makes financial sense to sustain.

Risks

• The proposed transaction may not close for any reason.
• The transaction could disrupt current business, plans, and operations.
• Diversion of management's attention from ongoing business activities.
• The company may face challenges in retaining and hiring key personnel.
• Competitive responses to the proposed transaction could impact the business.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• The company's ability to successfully execute its business strategy, including with respect to its IoT business, is subject to risks.
• The company's ability to capitalize on trends in its business and penetrate the healthcare and other specialty markets is not guaranteed.
• The effect of competition on Identiv's business could impact results.
• The company's ability to satisfy customer demand and expectations is subject to risks.
• The level and timing of customer orders and changes/cancellations could impact revenue.
• The loss of customers, suppliers, or partners could negatively affect the business.
• Industry trends and seasonality could impact results.
• The impact of macroeconomic conditions and customer demand, inflation and increases in prices could affect the business.

Future Outlook

Identiv expects to close the strategic transaction in Q3 2024 and anticipates Q2 2024 revenue to be in the range of $23 to $25 million. The company aims to transform major industries and create value by establishing a strong position in the healthcare and other high-value end markets with its IoT business.

Management Comments

• CEO Steven Humphreys stated that the first quarter was one of the most important in the company's history.
• CEO Steven Humphreys believes the transaction positions Identiv to build an enduring, leading IoT company.
• Kirsten Newquist expressed excitement about the opportunity to lead the IoT business and capitalize on its potential.
• Kirsten Newquist sees opportunities for RFID-enabled solutions to become a critical asset in the healthcare industry's digital transformation.
• Kirsten Newquist emphasized the importance of building a plan to drive operational excellence and develop strategic clarity and focus.

Industry Context

Identiv's strategic shift towards IoT aligns with the growing trend of digital transformation across various industries, particularly in healthcare. The company aims to capitalize on the increasing demand for RFID-enabled solutions in areas such as medication authentication, diagnostic test authentication, and condition monitoring of critical drugs. This move positions Identiv to compete with other players in the IoT space, focusing on specialty applications and higher-margin opportunities.

Comparison to Industry Standards

• Identiv's focus on specialty IoT technologies, particularly in HF/NFC and dual-frequency applications, differentiates it from competitors primarily serving high-volume UHF-based applications.
• Kirsten Newquist's experience at Avery Dennison Smartrac, a strong company in the RFID space, provides valuable insights and expertise.
• The company's transition to the Thailand facility aims to improve cost structure and compete more effectively with companies that have already established low-cost manufacturing capabilities.
• The involvement of Manfred Rietzler, the founder of Smartrac, as a Board advisor, brings additional industry knowledge and guidance.
• The participation of Dr. Rick Kuntz, previously Chief Medical and Scientific Officer for Medtronic, and Laura Angelini, previously a senior MedTech executive with Baxter Healthcare and Johnson & Johnson, provides valuable expertise in the healthcare sector.

Management Changes

Stakeholder Impact

• Shareholders will be impacted by the strategic shift and the potential for value creation in the IoT business.
• Employees in the security business will be transitioning to the buyer, Vitaprotech.
• Employees in the IoT business will be under new leadership and focused on growth opportunities.
• Customers of the security business will be served by Vitaprotech.
• Customers of the IoT business will benefit from increased investment and focus on innovative solutions.

Next Steps

• File the definitive proxy statement with the SEC.
• Announce the date for the annual meeting and stockholder vote on the transaction.
• Attend the B. Riley Conference on May 22nd.
• Craig-Hallum will be arranging a fireside chat session in early June.
• Share business updates following the shareholder vote and AGM.
• Complete onboarding and business deep dive for Kirsten Newquist.
• Build a plan to drive to operational excellence.
• Develop strategic clarity and focus along with a detailed growth and go-to-market plan.
• Accelerate the transition of the majority of RFID production to the Thailand facility.

Key Dates

Keywords

IoT, RFID, Divestiture, Healthcare, Security, Financial Results, Kirsten Newquist, Thailand Facility, Strategic Review, Asset Sale